UNIVERSITY OF CALIFORNIA SAN DIEGO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1960-11-18
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucsd.edu
Gabapentin and Tizanidine for Insomnia in Chronic Pain
Phase 2
Completed
- Conditions
- Insomnia Due to Medical ConditionChronic Pain
- Interventions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 9
- Registration Number
- NCT04429347
- Locations
- 🇺🇸
Center for Pain Medicine, UC San Diego, La Jolla, California, United States
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
Phase 2
Terminated
- Conditions
- Acute Myeloid Leukemia, AdultAMLAML, Adult
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 2
- Registration Number
- NCT04425655
- Locations
- 🇺🇸
UCSD Moores Cancer Center, La Jolla, California, United States
DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV
Phase 4
Completed
- Conditions
- HIV/AIDS
- Interventions
- Device: Digital Health Feedback System(DHFS)
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 16
- Registration Number
- NCT04418037
- Locations
- 🇺🇸
UCSD AntiViral Research Center, San Diego, California, United States
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
Phase 2
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 28
- Registration Number
- NCT04414930
- Locations
- 🇺🇸
Clinical Teaching Facility (CTF-B102) at UCSD Medical Center, San Diego, California, United States
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
- First Posted Date
- 2020-06-02
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 120
- Registration Number
- NCT04411225
- Locations
- 🇺🇸
UC San Diego, La Jolla, California, United States
🇺🇸University of California, San Diego, San Diego, California, United States
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
Completed
- Conditions
- Liver InflammationNonalcoholic SteatohepatitisLiver FibrosesNonalcoholic Fatty Liver
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 30
- Registration Number
- NCT04389593
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
Glutathione-rich Foods for Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Other: GSH FoodsOther: Standard of care nutrition education for type 2 diabetesOther: Nutrition education about glutathione sources in the diet
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 12
- Registration Number
- NCT04386187
- Locations
- 🇺🇸
University of California, San Diego, San Diego, California, United States
Ramipril for the Treatment of COVID-19
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 160
- Registration Number
- NCT04366050
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
Evaluation of Patient Reported Knowledge and Satisfaction Following the Use of an Enhanced Gynecologic Brachytherapy-Specific Educational Video
Not Applicable
Completed
- Conditions
- Cervical CancerUterine Cancer
- Interventions
- Other: Brachytherapy videoOther: Standard Brachytherapy Consent Process
- First Posted Date
- 2020-04-27
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 80
- Registration Number
- NCT04363957
- Locations
- 🇺🇸
Moores UC San Diego Cancer Center, La Jolla, California, United States
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
Phase 2
Completed
- Conditions
- MigraineCannabisTHCCBD
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 92
- Registration Number
- NCT04360044
- Locations
- 🇺🇸
Center for Pain Medicine, UC San Diego, La Jolla, California, United States
© Copyright 2025. All Rights Reserved by MedPath